Do I get upset with short attacks obcoarse. What eases my pain is buying more at nearly the 52 week low. I could list about 25 things that have put CYDY in the best shape financially but more importantly on the approval fronts CYDY has never been so close to 2 separate approvals for covid and HIV this year. Covid could come a lot sooner and we may already be generating revenue from Phillipines. This stock value to me is worth $10+ today before confirming any revenue based just on likely hood to succeed at hiv never mind all the other indications of 20+ cancers, bash, covid-19 severe critically ill and covid-19 longhaulers. India and Brazil are in crisis mode and a compassionate use over there would be as good as gold for revenue to come in only difference with EUA is marketing but leronlimab is getting more known worldwide stage everyday.